Obagi Medical Products, Inc. (OMPI) Tops Q2 EPS by 4c
Tweet Send to a FriendGet Alerts OMPI Hot Sheet
Price: $23.98 --0%
EPS Growth %: -37.5%
Financial Fact:
Cost of sales: 5.89M
Today's EPS Names:
NED, OESX, WSTL, More
EPS Growth %: -37.5%
Financial Fact:
Cost of sales: 5.89M
Today's EPS Names:
NED, OESX, WSTL, More
Trade OMPI Now!
Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q2 EPS of $0.18, $0.04 better than the analyst estimate of $0.14. Revenue for the quarter came in at $30.5 million versus the consensus estimate of $30.39 million.
For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Target Corp. (TGT) Misses Q1 Views, Issues Mixed Outlook
- Seaworld Ent. (SEAS) Narrows Q1 Loss to 49c/Share; Guides FY13 Revs
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
